Contract HHSD2002016F88916
Heyltex Corporation · Department Of Health And Human Services · September 24, 2021
Heyltex Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 24, 2021 for $3.38 million of work in pharmaceutical preparation manufacturing. Performance is in Katy, TX. This is a task or delivery order issued under parent IDIQ V797P5251B. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $22.58 million.
Contract details
- PIID
- HHSD2002016F88916
- Parent IDIQ
- V797P5251B
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Katy, TX
- First action
- September 24, 2021
Description
TO PROCURE FY21 REQUIRED QUANTITY OF PRUSSIAN BLUE FOR (RADIOGARDASE) INSOLUBLE CAP 500 MG ORAL
Modification timeline
-
September 24, 2021Mod P00007 · Exercise An Option$19.20M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002016F88916?
Contract HHSD2002016F88916 is a federal contract awarded to Heyltex Corporation by Department Of Health And Human Services on September 24, 2021 for $3.38 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSD2002016F88916?
Heyltex Corporation won contract HHSD2002016F88916 from Department Of Health And Human Services.
How much is contract HHSD2002016F88916 worth?
Contract HHSD2002016F88916 has obligated $3.38 million to date, with a total potential value of $22.58 million if all options are exercised.